Literature DB >> 31725875

Microbial Shifts and Shorter Time to Bowel Resection Surgery Associated with C. difficile in Pediatric Crohn's Disease.

Jennifer Hellmann1, Heidi Andersen2, Lin Fei3, Aaron Linn1, Ramona Bezold1, Kathleen Lake1, Kimberly Jackson1, Danielle Meyer1, Kelsie Dirksing1, Erin Bonkowski1, Nicholas J Ollberding3, David B Haslam2, Lee Denson1.   

Abstract

BACKGROUND: Clostridioides difficile infection and colonization are common in pediatric Crohn's disease (CD). Our aims were to test the relationship between C. difficile positivity and bowel resection surgery and to characterize microbial shifts associated with C. difficile carriage and surgery.
METHODS: A retrospective single-center study of 75 pediatric CD patients tested for association between C. difficile carriage and bowel resection surgery. A prospective single-center study of 70 CD patients utilized C. difficile testing and shotgun metagenomic sequencing of fecal samples to define microbiota variation stratified by C. difficile carriage or history of surgery.
RESULTS: The rate of bowel resection surgery increased from 21% in those without C. difficile to 67% in those with (P = 0.003). From a Kaplan-Meier survival model, the hazard ratio for time to first surgery was 4.4 (95% CI, 1.2-16.2; P = 0.00) in patients with positive C. difficile testing in the first year after diagnosis. Multivariable logistic regression analysis confirmed this association (odds ratio 16.2; 95% CI, 2.2-120; P = 0.006). Larger differences in microbial abundance and metabolic pathways were observed in patients with prior surgery than in those with C. difficile carriage. Depletion of Alistipes and Ruminococcus species and reduction in methionine biosynthesis were noted in patients with both C. difficile carriage and past surgery.
CONCLUSIONS: A positive C. difficile test during the first year after diagnosis is associated with decreased time to first bowel resection surgery in pediatric Crohn's disease. Depletion of beneficial commensals and methionine biosynthesis in patients with C. difficile carriage may contribute to increased risk for surgery.
© 2019 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 C. difficile infection; bowel resection surgery; fecal microbiome; pediatric inflammatory bowel disease; shotgun metagenomic sequencing

Mesh:

Substances:

Year:  2020        PMID: 31725875      PMCID: PMC7365806          DOI: 10.1093/ibd/izz263

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   7.290


  35 in total

1.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.

Authors:  Edward V Loftus
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

2.  Testing for Clostridium difficile in patients newly diagnosed with inflammatory bowel disease in a community setting.

Authors:  Anita Krishnarao; Lauren de Leon; Renee Bright; Heather Moniz; Meaghan Law; Neal Leleiko; Bruce E Sands; Marjorie Merrick; Jason Shapiro; Sylvan Wallenstein; Julie Giacalone; Samir A Shah
Journal:  Inflamm Bowel Dis       Date:  2015-03       Impact factor: 5.325

3.  Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease.

Authors:  James D Lewis; Eric Z Chen; Robert N Baldassano; Anthony R Otley; Anne M Griffiths; Dale Lee; Kyle Bittinger; Aubrey Bailey; Elliot S Friedman; Christian Hoffmann; Lindsey Albenberg; Rohini Sinha; Charlene Compher; Erin Gilroy; Lisa Nessel; Amy Grant; Christel Chehoud; Hongzhe Li; Gary D Wu; Frederic D Bushman
Journal:  Cell Host Microbe       Date:  2017-08-09       Impact factor: 21.023

4.  Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.

Authors:  Subra Kugathasan; Lee A Denson; Thomas D Walters; Mi-Ok Kim; Urko M Marigorta; Melanie Schirmer; Kajari Mondal; Chunyan Liu; Anne Griffiths; Joshua D Noe; Wallace V Crandall; Scott Snapper; Shervin Rabizadeh; Joel R Rosh; Jason M Shapiro; Stephen Guthery; David R Mack; Richard Kellermayer; Michael D Kappelman; Steven Steiner; Dedrick E Moulton; David Keljo; Stanley Cohen; Maria Oliva-Hemker; Melvin B Heyman; Anthony R Otley; Susan S Baker; Jonathan S Evans; Barbara S Kirschner; Ashish S Patel; David Ziring; Bruce C Trapnell; Francisco A Sylvester; Michael C Stephens; Robert N Baldassano; James F Markowitz; Judy Cho; Ramnik J Xavier; Curtis Huttenhower; Bruce J Aronow; Greg Gibson; Jeffrey S Hyams; Marla C Dubinsky
Journal:  Lancet       Date:  2017-03-02       Impact factor: 79.321

5.  Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis.

Authors:  Grant E Barber; Steven Hendler; Philip Okafor; David Limsui; Berkeley N Limketkai
Journal:  Inflamm Bowel Dis       Date:  2018-07-12       Impact factor: 5.325

6.  Dynamics of the human gut microbiome in inflammatory bowel disease.

Authors:  Jonas Halfvarson; Colin J Brislawn; Regina Lamendella; Yoshiki Vázquez-Baeza; William A Walters; Lisa M Bramer; Mauro D'Amato; Ferdinando Bonfiglio; Daniel McDonald; Antonio Gonzalez; Erin E McClure; Mitchell F Dunklebarger; Rob Knight; Janet K Jansson
Journal:  Nat Microbiol       Date:  2017-02-13       Impact factor: 17.745

7.  Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.

Authors:  Melanie Schirmer; Eric A Franzosa; Jason Lloyd-Price; Lauren J McIver; Randall Schwager; Tiffany W Poon; Ashwin N Ananthakrishnan; Elizabeth Andrews; Gildardo Barron; Kathleen Lake; Mahadev Prasad; Jenny Sauk; Betsy Stevens; Robin G Wilson; Jonathan Braun; Lee A Denson; Subra Kugathasan; Dermot P B McGovern; Hera Vlamakis; Ramnik J Xavier; Curtis Huttenhower
Journal:  Nat Microbiol       Date:  2018-01-08       Impact factor: 17.745

Review 8.  Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.

Authors:  Ramnik J Xavier; Curtis Huttenhower; Jason Lloyd-Price; Cesar Arze; Ashwin N Ananthakrishnan; Melanie Schirmer; Julian Avila-Pacheco; Tiffany W Poon; Elizabeth Andrews; Nadim J Ajami; Kevin S Bonham; Colin J Brislawn; David Casero; Holly Courtney; Antonio Gonzalez; Thomas G Graeber; A Brantley Hall; Kathleen Lake; Carol J Landers; Himel Mallick; Damian R Plichta; Mahadev Prasad; Gholamali Rahnavard; Jenny Sauk; Dmitry Shungin; Yoshiki Vázquez-Baeza; Richard A White; Jonathan Braun; Lee A Denson; Janet K Jansson; Rob Knight; Subra Kugathasan; Dermot P B McGovern; Joseph F Petrosino; Thaddeus S Stappenbeck; Harland S Winter; Clary B Clish; Eric A Franzosa; Hera Vlamakis
Journal:  Nature       Date:  2019-05-29       Impact factor: 49.962

9.  Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.

Authors:  Marjolein A Y Klaassen; Floris Imhann; Valerie Collij; Jingyuan Fu; Cisca Wijmenga; Alexandra Zhernakova; Gerard Dijkstra; Eleonora A M Festen; Ranko Gacesa; Arnau Vich Vila; Rinse K Weersma
Journal:  J Crohns Colitis       Date:  2019-10-28       Impact factor: 9.071

10.  Species-level functional profiling of metagenomes and metatranscriptomes.

Authors:  Eric A Franzosa; Lauren J McIver; Gholamali Rahnavard; Luke R Thompson; Melanie Schirmer; George Weingart; Karen Schwarzberg Lipson; Rob Knight; J Gregory Caporaso; Nicola Segata; Curtis Huttenhower
Journal:  Nat Methods       Date:  2018-10-30       Impact factor: 28.547

View more
  8 in total

Review 1.  Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis.

Authors:  Sheng-Bo Fang; Yan-Qing Song; Chun-Yan Zhang; Li-Bo Wang
Journal:  World J Pediatr       Date:  2021-11-20       Impact factor: 2.764

2.  Hospitalization With Clostridioides difficile in Pediatric Inflammatory Bowel Disease: a Population-Based Study.

Authors:  M Ellen Kuenzig; Eric I Benchimol; Charles N Bernstein; Alain Bitton; Matthew W Carroll; Anne M Griffiths; Gilaad G Kaplan; Geoffrey C Nguyen; Anthony R Otley; Therese A Stukel; Trevor J B Dummer; Wael El-Matary; Kevan Jacobson; Jennifer L Jones; Lisa M Lix; David R Mack; Sanjay K Murthy; Juan-Nicolás Peña-Sánchez; Laura E Targownik; Stephen G Fung; Sarah Spruin; Stephanie Coward; Yunsong Cui; Christopher Filliter; Zoann Nugent; Shabnaz Siddiq; Harminder Singh
Journal:  J Pediatr Gastroenterol Nutr       Date:  2022-06-07       Impact factor: 3.288

3.  Antibiotic exposure prevents acquisition of beneficial metabolic functions in the preterm infant gut microbiome.

Authors:  Yanping Xu; Olivia Milburn; Traci Beiersdorfer; Lizhong Du; Henry Akinbi; David B Haslam
Journal:  Microbiome       Date:  2022-07-07       Impact factor: 16.837

4.  Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease.

Authors:  Allison D Ta; Nicholas J Ollberding; Rebekah Karns; Yael Haberman; Adina L Alazraki; David Hercules; Robert Baldassano; James Markowitz; Melvin B Heyman; Sandra Kim; Barbara Kirschner; Jason M Shapiro; Joshua Noe; Maria Oliva-Hemker; Anthony Otley; Marian Pfefferkorn; Richard Kellermayer; Scott Snapper; Shervin Rabizadeh; Ramnik Xavier; Marla Dubinsky; Jeffrey Hyams; Subra Kugathasan; Anil G Jegga; Jonathan R Dillman; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2021-10-20       Impact factor: 5.325

5.  MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.

Authors:  C Rodríguez; E Romero; L Garrido-Sanchez; G Alcaín-Martínez; R J Andrade; B Taminiau; G Daube; E García-Fuentes
Journal:  Gut Microbes       Date:  2020-03-04

Review 6.  Updating changes in human gut microbial communities associated with Clostridioides difficile infection.

Authors:  Giovanny Herrera; Daniel Paredes-Sabja; Manuel Alfonso Patarroyo; Juan David Ramírez; Marina Muñoz
Journal:  Gut Microbes       Date:  2021 Jan-Dec

7.  Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease: A Clinician's Dilemma.

Authors:  Máire A Conrad; Judith R Kelsen
Journal:  J Pediatric Infect Dis Soc       Date:  2021-11-17       Impact factor: 5.235

8.  Decreased secondary faecal bile acids in children with ulcerative colitis and Clostridioides difficile infection.

Authors:  Sarah Rotondo-Trivette; Beibei Wang; Christopher Gayer; Riddhi Parsana; Yihui Luan; Fengzhu Sun; Sonia Michail
Journal:  Aliment Pharmacol Ther       Date:  2021-07-04       Impact factor: 9.524

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.